SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63376 356 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
62449One of my issues with biopharma investing, has been the relative failure of compallatwwk-2/20/2024
62448I am interested in Spyre as well. Before jumping in there I am curious about theIMMUzombie-2/18/2024
62447SYRE and GLUE Ghetto: Yeah, the numbers seem to be screwy, it hurts my head toerickerickson-2/17/2024
62446Wow 45%. I'm seeing 36M shares outstanding on most sites. That is strange, sghettogoulash-2/17/2024
62445I do not see that AVORO owns any GLUE. I must be missing something but it's galt-2/17/2024
62444"I am currently looking at some new ideas to invest my CBAY earnings" erickerickson12/17/2024
62443Just finished “For Blood and Money” Billionaires, Biotech, and the quest for bloidahoranch142/16/2024
62442Edit: 3/1 callsghettogoulash-2/16/2024
62441Haha. This should lend credibility to the entire platform, which is pretty impreghettogoulash-2/16/2024
62440Never mind.Stikkmann-2/16/2024
62439Iovance Approved globenewswire.combnutman12/16/2024
62438I am currently looking at some new ideas to invest my CBAY earnings and might beIMMUzombie-2/16/2024
62437Anybody have a take on IOVA’s PDUFA date coming up? Management kind of hinted oStikkmann-2/16/2024
62436SRPT news: Sarepta Therapeutics Announces U.S. FDA Acceptance of an Efficacy Suerickerickson22/16/2024
62435I'm confused by Bluebird as well. 3 FDA approved products. $0.00 debt. Thesummer_sky-2/16/2024
62434ALT data was good. Two events I am looking for. In Q1 they are supposed to repstockdoc7742/15/2024
62433Good to see that Avoro did not bail on AADI. Shares remain unchanged at 2,849,40ghettogoulash32/15/2024
62432I have a considerable amount of AUPH, but, like Idaho, its a small part of my hogalt22/15/2024
62431It’s one of those stocks that is really frustrating. An unmet need drug that is idahoranch142/15/2024
62430They should FIRE Peter Greenleaf and bring in a real CEO who knows what the hellplhky3465-2/15/2024
62429AUPH: Apparently no buyout Down 25% pre-market. From Reuters (sorry, no link I erickerickson-2/15/2024
62428I got the live short interest today from someone who pays for the service. Itghettogoulash32/14/2024
62427Just sent this email to the CEO. He's a former analyst at Citadel and took pghettogoulash12/14/2024
62426Biogen perspective....Is it just me, but I am gratified that Biogen/IDEC is readscorman1-2/14/2024
62425Avg. Volume: 121,223 Today's Volume: 69,508,221 Float: 778,000 The entire fghettogoulash-2/13/2024
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News